Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)
8.16
+0.07 (0.87%)
Apr 29, 2026, 3:00 PM CST
SHA:600789 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 86.56 | 111.91 | 394.62 | 246.17 | 138.01 | 89.1 |
Depreciation & Amortization | 449.07 | 449.07 | 399.01 | 381.13 | 348.12 | 307.46 |
Other Amortization | 0.47 | 0.47 | 3 | 1.44 | 1.88 | 2.25 |
Loss (Gain) From Sale of Assets | -0.17 | -0.17 | -153.42 | -0.28 | -2.83 | -0.16 |
Asset Writedown & Restructuring Costs | 45.98 | 45.98 | 133.82 | 109.36 | 1 | 0.68 |
Loss (Gain) From Sale of Investments | 5.22 | 5.22 | 7.56 | 7.2 | 6.53 | 3.18 |
Provision & Write-off of Bad Debts | - | - | 2.52 | 0.98 | 8.42 | 24.39 |
Other Operating Activities | 232.32 | 69.72 | 25.89 | 32.83 | 163.54 | 113.83 |
Change in Accounts Receivable | 169.33 | 169.33 | -265.44 | -124.56 | -516.07 | -83.45 |
Change in Inventory | 191.09 | 191.09 | -145.06 | 7.62 | -314.68 | -356.13 |
Change in Accounts Payable | -331.3 | -331.3 | -7.36 | -53.29 | 614.77 | 78.61 |
Change in Other Net Operating Assets | 3.35 | 3.35 | 0.69 | 0.45 | - | - |
Operating Cash Flow | 835.43 | 698.17 | 402.82 | 604.01 | 444.38 | 177.49 |
Operating Cash Flow Growth | 213.08% | 73.32% | -33.31% | 35.92% | 150.36% | -24.33% |
Capital Expenditures | -331.68 | -338.86 | -279.18 | -337.91 | -428.36 | -488.57 |
Sale of Property, Plant & Equipment | 122.96 | 104.2 | 20.31 | 0.03 | 0.15 | 1.34 |
Divestitures | - | - | - | 2.13 | - | - |
Investment in Securities | 1.19 | 1.19 | - | - | -15.82 | -42.18 |
Other Investing Activities | 22.57 | - | - | -34.03 | 0.03 | -4.99 |
Investing Cash Flow | -184.96 | -233.47 | -258.87 | -369.78 | -444.01 | -534.4 |
Long-Term Debt Issued | - | 1,875 | 1,676 | 2,179 | 2,145 | 2,577 |
Total Debt Issued | 1,624 | 1,875 | 1,676 | 2,179 | 2,145 | 2,577 |
Long-Term Debt Repaid | - | -1,639 | -1,814 | -2,198 | -1,973 | -2,144 |
Total Debt Repaid | -1,749 | -1,639 | -1,814 | -2,198 | -1,973 | -2,144 |
Net Debt Issued (Repaid) | -125.24 | 235.98 | -137.41 | -18.57 | 171.81 | 432.68 |
Issuance of Common Stock | 1,187 | 1,187 | 17.36 | 61.88 | 41.76 | 1.98 |
Common Dividends Paid | -162.89 | -166.3 | -233.49 | -143.73 | -139.59 | -166.39 |
Other Financing Activities | -101.68 | -101 | 164.44 | 6.5 | -79.29 | -6.95 |
Financing Cash Flow | 797.02 | 1,156 | -189.1 | -93.92 | -5.31 | 261.32 |
Foreign Exchange Rate Adjustments | -4.06 | 2.24 | 10.81 | 2.7 | 6.46 | 0.83 |
Net Cash Flow | 1,443 | 1,622 | -34.34 | 143.01 | 1.52 | -94.76 |
Free Cash Flow | 503.75 | 359.31 | 123.64 | 266.09 | 16.02 | -311.07 |
Free Cash Flow Growth | 1900.13% | 190.62% | -53.54% | 1561.36% | - | - |
Free Cash Flow Margin | 8.82% | 6.23% | 1.98% | 4.33% | 0.29% | -6.32% |
Free Cash Flow Per Share | 0.51 | 0.38 | 0.14 | 0.30 | 0.02 | -0.35 |
Cash Income Tax Paid | 152.67 | 154.41 | 130.55 | 231.16 | 65.86 | 104.04 |
Levered Free Cash Flow | 831.52 | 543.7 | -253.58 | -59 | -39.51 | -436.35 |
Unlevered Free Cash Flow | 831.52 | 543.7 | -206.47 | -9.51 | 21.77 | -395.64 |
Change in Working Capital | 15.97 | 15.97 | -410.17 | -174.83 | -220.3 | -363.25 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.